Secondary |
Pain |
13.8% |
Product Used For Unknown Indication |
13.2% |
Depression |
9.8% |
Drug Use For Unknown Indication |
8.0% |
Weight Loss Diet |
7.5% |
Blood Pressure Abnormal |
5.7% |
Peritoneal Dialysis |
5.7% |
Hypertension |
5.2% |
Multiple Myeloma |
3.4% |
Post-traumatic Stress Disorder |
3.4% |
Extrasystoles |
2.9% |
Gastrooesophageal Reflux Disease |
2.9% |
Heart Rate Irregular |
2.9% |
Migraine |
2.9% |
Rheumatoid Arthritis |
2.9% |
Therapy Change |
2.9% |
Arthralgia |
1.7% |
Back Pain |
1.7% |
Drug Dependence |
1.7% |
Haemorrhoid Operation |
1.7% |
|
Weight Increased |
30.5% |
Tremor |
18.6% |
Confusional State |
8.5% |
Constipation |
5.1% |
Weight Decreased |
5.1% |
Pain |
3.4% |
Somnolence |
3.4% |
Vomiting |
3.4% |
Wrong Drug Administered |
3.4% |
Adverse Event |
1.7% |
Aggression |
1.7% |
Anxiety |
1.7% |
Application Site Pain |
1.7% |
Asthenia |
1.7% |
Blood Pressure Decreased |
1.7% |
Dehydration |
1.7% |
Diarrhoea |
1.7% |
Drug Dose Omission |
1.7% |
Eye Pain |
1.7% |
Faeces Discoloured |
1.7% |
|
Concomitant |
Product Used For Unknown Indication |
15.8% |
Pain |
14.4% |
Drug Use For Unknown Indication |
12.6% |
Rheumatoid Arthritis |
6.9% |
Crohn's Disease |
5.2% |
Chronic Obstructive Pulmonary Disease |
4.3% |
Hypertension |
4.2% |
Multiple Sclerosis |
4.0% |
Gastrooesophageal Reflux Disease |
3.7% |
Depression |
3.6% |
Medulloblastoma |
3.6% |
Back Pain |
3.4% |
Asthma |
3.0% |
Anxiety |
2.7% |
Nuclear Magnetic Resonance Imaging |
2.6% |
Hepatitis C |
2.5% |
Vitamin Supplementation |
2.4% |
Bipolar Disorder |
1.8% |
Prophylaxis |
1.8% |
Arthritis |
1.7% |
|
Pain |
10.3% |
Weight Decreased |
9.8% |
Nausea |
7.5% |
Vomiting |
7.5% |
Drug Ineffective |
6.9% |
Urinary Tract Infection |
6.9% |
Pain In Extremity |
6.3% |
Death |
5.7% |
Pharmaceutical Product Complaint |
4.6% |
Weight Increased |
4.6% |
Dyspnoea |
4.0% |
Pancreatic Carcinoma |
3.4% |
Pneumonia |
3.4% |
Product Quality Issue |
3.4% |
Malaise |
2.9% |
Rash |
2.9% |
Sepsis |
2.9% |
Arthralgia |
2.3% |
Drug Dose Omission |
2.3% |
Fatigue |
2.3% |
|
Interacting |
Product Used For Unknown Indication |
100.0% |
|
|